Enhancement of transcriptional activity of mutant p53 tumor suppressor protein through stabilization of tetramer formation by calix[6]arene derivatives

被引:31
|
作者
Kamada, Rui [1 ]
Yoshino, Wataru [1 ]
Nomura, Takao [1 ]
Chuman, Yoshiro [1 ]
Imagawa, Toshiaki [1 ]
Suzuki, Takanori [2 ]
Sakaguchi, Kazuyasu [1 ]
机构
[1] Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab,Kita Ku, Sapporo, Hokkaido 0600810, Japan
[2] Hokkaido Univ, Fac Sci, Dept Chem, Lab Organ Chem 1, Sapporo, Hokkaido 0600810, Japan
关键词
Calixarene; Li-Fraumeni syndrome; p53; mutation; Stabilization; Tetramerization domain; LI-FRAUMENI; DOMAIN; MUTATIONS; STABILITY; MECHANISM; CANCER;
D O I
10.1016/j.bmcl.2010.06.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Li-Fraumeni syndrome, a hereditary disorder characterized by familial clusters of early-onset multiple tumors, is caused by mutation of the TP53 gene, which encodes the p53 tumor suppressor protein. Mutation of Arg337 to histidine in the tetramerization domain of p53 is most frequently observed in Li-Fraumeni syndrome. This mutation is reported to destabilize the tetrameric structure of p53. We designed and synthesized calix[6] arene derivatives, which have six imidazole or pyrazole groups at the upper rim. In this study, we report, for the first time, the enhancement of the in vivo transcriptional activity of the most common Li-Fraumeni p53 mutant by imidazole-calix[6] arene through stabilization of the oligomer formation. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4412 / 4415
页数:4
相关论文
共 48 条
  • [1] Tetramer Formation of Tumor Suppressor Protein p53: Structure, Function, and Applications
    Kamada, Rui
    Toguchi, Yu
    Nomura, Takao
    Imagawa, Toshiaki
    Sakaguchi, Kazuyasu
    BIOPOLYMERS, 2016, 106 (04) : 598 - 612
  • [2] Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53
    da Costa, Nathalia Meireles
    Hautefeuille, Agnes
    Cros, Marie-Pierre
    Melendez, Matias Eliseo
    Waters, Timothy
    Swann, Peter
    Hainaut, Pierre
    Ribeiro Pinto, Luis Felipe
    CELL CYCLE, 2012, 11 (24) : 4570 - 4578
  • [3] NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization
    Cubillos-Rojas, Monica
    Schneider, Taiane
    Bartrons, Ramon
    Ventura, Francesc
    Luis Rosa, Jose
    ONCOTARGET, 2017, 8 (37) : 61824 - 61836
  • [4] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
  • [5] CYCLIN-G IS A TRANSCRIPTIONAL TARGET OF THE P53 TUMOR-SUPPRESSOR PROTEIN
    OKAMOTO, K
    BEACH, D
    EMBO JOURNAL, 1994, 13 (20) : 4816 - 4822
  • [6] Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity
    Viotti, J.
    Duplan, E.
    Caillava, C.
    Condat, J.
    Goiran, T.
    Giordano, C.
    Marie, Y.
    Idbaih, A.
    Delattre, J-Y
    Honnorat, J.
    Checler, F.
    Alves Da Costa, C.
    ONCOGENE, 2014, 33 (14) : 1764 - 1775
  • [7] Enhancement of fibrogenesis by the p53 tumor suppressor protein in asbestos-exposed rodents
    Nelson, A
    Mendoza, T
    Hoyle, GW
    Brody, AR
    Fermin, C
    Morris, GF
    CHEST, 2001, 120 (01) : 33S - 34S
  • [8] Human smooth muscle α-actin gene is a transcriptional target of the p53 tumor suppressor protein
    Katherine A Comer
    Phillip A Dennis
    Lydia Armstrong
    Joseph J Catino
    Michael B Kastan
    C Chandra Kumar
    Oncogene, 1998, 16 : 1299 - 1308
  • [9] Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation
    Miyajima, Chiharu
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (04) : 618 - 624
  • [10] Human smooth muscle α-actin gene is a transcriptional target of the p53 tumor suppressor protein
    Comer, KA
    Dennis, PA
    Armstrong, L
    Catino, JJ
    Kastan, MB
    Kumar, CC
    ONCOGENE, 1998, 16 (10) : 1299 - 1308